GUARDANT HEALTH, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
GUARDANT HEALTH, INC. (GH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.00 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-07-30
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-03-31 was $57.40, a 112.20% increase year-over-year.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-09-30 was $28.36, a 46.04% increase year-over-year.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-06-30 was $30.62, a 81.72% increase year-over-year.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $28.32, a 64.65% increase from fiscal 2024.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $17.20, a 13.57% decline from fiscal 2023.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $19.90, a 30.44% decline from fiscal 2022.
- GUARDANT HEALTH, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $28.61, a 59.27% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-30 | $57.40 10-Q · filed 2026-07-30 | ||
| 2026-03-31 | $57.40 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $28.32 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $28.36 10-Q · filed 2025-10-29 | $27.54 10-Q · filed 2025-10-29 | ||
| 2025-06-30 | $30.62 10-Q · filed 2026-07-30 | $27.49 10-Q · filed 2026-07-30 | ||
| 2025-03-31 | $27.05 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $17.20 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $19.42 10-Q · filed 2025-10-29 | $15.35 10-Q · filed 2025-10-29 | ||
| 2024-06-30 | $16.85 10-Q · filed 2025-07-30 | $14.87 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $12.92 10-Q · filed 2025-04-30 | |||
| 2023-12-31 | $19.90 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $24.42 10-Q · filed 2024-11-06 | $22.39 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $20.90 10-Q · filed 2024-08-07 | $20.75 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $19.82 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $28.61 10-K · filed 2025-02-20 | |||
| 2022-09-30 | $33.66 10-Q · filed 2023-11-06 | $26.49 10-Q · filed 2023-11-06 | ||
| 2022-06-30 | $23.41 10-Q · filed 2023-08-03 | $23.67 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $36.32 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $70.25 10-K · filed 2024-02-22 | |||
| 2021-09-30 | $65.17 10-Q · filed 2022-11-03 | $72.14 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $81.79 10-Q · filed 2022-08-04 | $84.02 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $101.21 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $48.99 10-K · filed 2023-02-23 | |||
| 2020-09-30 | $49.73 10-Q · filed 2021-11-04 | $46.85 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $44.61 10-Q · filed 2021-08-05 | $45.52 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $55.05 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $52.37 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $55.16 10-Q · filed 2020-11-05 | $53.02 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $51.94 10-Q · filed 2020-08-06 | $43.35 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $25.90 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $5.17 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $5.45 10-Q · filed 2019-11-07 | $4.65 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $4.24 10-Q · filed 2019-08-07 | $4.06 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $3.77 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |